West Nile virus vaccine - Najit Technologies
Alternative Names: HydroVax-001; HydroVax-001B; Inactivated West Nile virus vaccine - Najit TechnologiesLatest Information Update: 24 Dec 2024
Price :
$50 *
At a glance
- Originator Najit Technologies
- Developer National Institute of Allergy and Infectious Diseases
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I West Nile virus infections
Most Recent Events
- 24 Dec 2024 West Nile virus vaccine is still in phase-I trials for West Nile virus infections(Prevention) in USA (IM, Injection) (NCT06745921) (NCT02337868)
- 20 Dec 2024 National Institute of Allergy and Infectious Diseases plans phase-I trial for West Nile virus infection (Prevention) in December 2024 (IM)Country) (NCT06745921)
- 28 Sep 2020 No recent reports of development identified for phase-I development in West Nile virus infections(Prevention) in USA (IM, Injection)